Jefferies Downgrades Pacira BioSciences to Hold, Announces $36 Price Target
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsDowngradesPrice Target
Jefferies analyst Glen Santangelo downgrades Pacira BioSciences (NASDAQ:PCRX) from Buy to Hold and announces $36 price target.
Jefferies analyst Glen Santangelo downgrades Pacira BioSciences (NASDAQ:PCRX) from Buy to Hold and announces $36 price target.